Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Multiple sclerosis and Alzheimer disease through the looking glass of MR imaging.

Literature DB >> 16286389

Multiple sclerosis and Alzheimer disease through the looking glass of MR imaging.

Giovanni B Frisoni¹, Massimo Filippi.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2005 PMID： 16286389 PMCID： PMC7976192

Source DB: PubMed Journal: AJNR Am J Neuroradiol ISSN： 0195-6108 Impact factor: 3.825

× No keyword cloud information.

56 in total

Review 1. Treatment of Alzheimer's disease.

Authors: R Mayeux; M Sano
Journal: N Engl J Med Date: 1999-11-25 Impact factor: 91.245

2. The predementia diagnosis of Alzheimer disease.

Authors: Giovanni B Frisoni; Alessandro Padovani; Lars-Olof Wahlund
Journal: Alzheimer Dis Assoc Disord Date: 2004 Apr-Jun Impact factor: 2.703

3. Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia.

Authors: C R Jack; D W Dickson; J E Parisi; Y C Xu; R H Cha; P C O'Brien; S D Edland; G E Smith; B F Boeve; E G Tangalos; E Kokmen; R C Petersen
Journal: Neurology Date: 2002-03-12 Impact factor: 9.910

4. White matter damage in Alzheimer's disease assessed in vivo using diffusion tensor magnetic resonance imaging.

Authors: M Bozzali; A Falini; M Franceschi; M Cercignani; M Zuffi; G Scotti; G Comi; M Filippi
Journal: J Neurol Neurosurg Psychiatry Date: 2002-06 Impact factor: 10.154

5. Combined Analysis of CSF Tau Levels and [(123)I]Iodoamphetamine SPECT in Mild Cognitive Impairment: Implications for a Novel Predictor of Alzheimer's Disease.

Authors: Nobuyuki Okamura; Hiroyuki Arai; Masahiro Maruyama; Makoto Higuchi; Toshifumi Matsui; Haruko Tanji; Takashi Seki; Hisao Hirai; Hiroshi Chiba; Masatoshi Itoh; Hidetada Sasaki
Journal: Am J Psychiatry Date: 2002-03 Impact factor: 18.112

Review 6. The potential of anti-inflammatory drugs for the treatment of Alzheimer's disease.

Authors: Paul S Aisen
Journal: Lancet Neurol Date: 2002-09 Impact factor: 44.182

7. Functional deactivations: change with age and dementia of the Alzheimer type.

Authors: Cindy Lustig; Abraham Z Snyder; Mehul Bhakta; Katherine C O'Brien; Mark McAvoy; Marcus E Raichle; John C Morris; Randy L Buckner
Journal: Proc Natl Acad Sci U S A Date: 2003-11-07 Impact factor: 11.205

8. Incorporating biomarkers into clinical drug trials in Alzheimer's disease.

Authors: John H. Growdon
Journal: J Alzheimers Dis Date: 2001-06 Impact factor: 4.472

9. Regional gray and white matter metabolite differences in subjects with AD, with subcortical ischemic vascular dementia, and elderly controls with 1H magnetic resonance spectroscopic imaging.

Authors: S MacKay; D J Meyerhoff; J M Constans; D Norman; G Fein; M W Weiner
Journal: Arch Neurol Date: 1996-02